Glimmer of hope in early Alzheimer’s disease
As the government sets out to prioritise earlier diagnosis of dementia, of which Alzheimer’s disease is the most common form, an innovative nutritional drink for the dietary management of early Alzheimer’s disease has become available in the UK. Souvenaid is the result of over 10 years’ research by leading neuroscientists into the nutritional needs of people living with the early Alzheimer's disease.
One of the key features of early Alzheimer’s disease is a loss of connections in the brain (known as synapses). These connections are essential to normal brain function as they allow brain cells (neurons) to share information. A combination of nutrients are required in the process of making new connections, in particular three key nutrients - DHA, choline and uridine which help with synapse production. These three nutrients act as ‘building blocks’ and are found in a normal diet. However, unfortunately, despite eating a normal diet, people living with Alzheimer’s disease have been shown to have relatively low levels of key nutrients in their bodies.
Souvenaid can help, as it contains a unique patented combination of nutrients at levels which are difficult to achieve from diet alone, including omega-3 polyunsaturated fatty acids, uridine and choline, together with phospholipids, B vitamins, vitamin C, vitamin E and selenium.
Dr David Wilkinson, Consultant in Old Age Psychiatry, commented: “Alzheimer’s disease is not part and parcel of aging but a serious and progressive disease of the brain which prevents us from being able to retain new memories. As we age, our bodies become less efficient at processing essential nutrients, meaning that we need to increase our intake of food to absorb the same amount of nutrients in order to maintain a healthy body. In the same way, we need the right nutrients for our brains to keep them healthy”.
Souvenaid is a “Food for Special Medical Purposes”, for the dietary management of early Alzheimer’s disease. It should be taken as part of an Alzheimer’s disease care plan. People with early Alzheimer’s disease must speak with a doctor, specialist nurse, dietician or pharmacist to see if Souvenaid is right for them.
It takes time for these nutrients to be taken up and used by the body, so there is no noticeable effect straight away. Therefore, it is important to keep taking Souvenaid every day to ensure a continuous and adequate supply of important nutrients for the brain. Normally Souvenaid is taken continuously every day for at least 3 months, however, people living with early Alzheimer’s disease should discuss how long to take Souvenaid with their healthcare professional.
Souvenaid, a new nutritional drink for the dietary management of early Alzheimer’s disease comes in two pleasant tasting flavours (vanilla and strawberry) and is designed to be incorporated into the daily routine, such as taking it at breakfast. Visit souvenaid.com for more information.
